Dipna Pharmachem (BOM:543594) Debt-to-EBITDA : 5.53 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dipna Pharmachem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹69 Mil. Dipna Pharmachem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹125 Mil. Dipna Pharmachem's annualized EBITDA for the quarter that ended in Mar. 2024 was ₹35 Mil. Dipna Pharmachem's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 5.53.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dipna Pharmachem's Debt-to-EBITDA or its related term are showing as below:

BOM:543594' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.66 Med: 6.77 Max: 34.19
Current: 5.67

During the past 5 years, the highest Debt-to-EBITDA Ratio of Dipna Pharmachem was 34.19. The lowest was 4.66. And the median was 6.77.

BOM:543594's Debt-to-EBITDA is ranked worse than
78.84% of 430 companies
in the Healthcare Providers & Services industry
Industry Median: 2.54 vs BOM:543594: 5.67

Dipna Pharmachem Debt-to-EBITDA Historical Data

The historical data trend for Dipna Pharmachem's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Debt-to-EBITDA Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-EBITDA

24.20

34.19

4.66

6.77

5.67

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial			3.57	4.41	5.51	5.36	5.53

Competitive Comparison of Dipna Pharmachem's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dipna Pharmachem's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dipna Pharmachem's Debt-to-EBITDA falls into.

Dipna Pharmachem Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dipna Pharmachem's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(68.98	+	125.47)	/	34.325
	=	5.66

Dipna Pharmachem's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(68.98	+	125.47)	/	35.17
	=	5.53

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Mar. 2024) EBITDA data.

Dipna Pharmachem (BOM:543594) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Dipna Pharmachem Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Dipna Pharmachem (BOM:543594) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380 055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others.

Dipna Pharmachem (BOM:543594) Headlines

No Headlines